These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30559899)
1. Seborrheic Keratoses - The Most Common Benign Skin Tumor of Humans. Clinical presentation and an update on pathogenesis and treatment options. Wollina U Open Access Maced J Med Sci; 2018 Nov; 6(11):2270-2275. PubMed ID: 30559899 [TBL] [Abstract][Full Text] [Related]
2. Advances in the Etiology, Detection, and Clinical Management of Seborrheic Keratoses. Sun MD; Halpern AC Dermatology; 2022; 238(2):205-217. PubMed ID: 34311463 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review. Natarelli N; Krenitsky A; Hennessy K; Moore S; Grichnik J J Dermatolog Treat; 2023 Dec; 34(1):2133532. PubMed ID: 36215682 [TBL] [Abstract][Full Text] [Related]
11. Are all seborrheic keratoses benign? Review of the typical lesion and its variants. Noiles K; Vender R J Cutan Med Surg; 2008; 12(5):203-10. PubMed ID: 18845088 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Hafner C; López-Knowles E; Luis NM; Toll A; Baselga E; Fernández-Casado A; Hernández S; Ribé A; Mentzel T; Stoehr R; Hofstaedter F; Landthaler M; Vogt T; Pujol RM; Hartmann A; Real FX Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13450-4. PubMed ID: 17673550 [TBL] [Abstract][Full Text] [Related]
13. The role of immunosuppression in squamous cell carcinomas arising in seborrheic keratosis. Conic RZ; Napekoski K; Schuetz H; Piliang M; Bergfeld W; Atanaskova Mesinkovska N J Am Acad Dermatol; 2017 Jun; 76(6):1146-1150. PubMed ID: 28162852 [TBL] [Abstract][Full Text] [Related]
14. Giant seborrheic keratoses on penis. Part M; Svecová D; Brezová D; Breza J J Sex Med; 2014 Dec; 11(12):3119-22. PubMed ID: 25135108 [TBL] [Abstract][Full Text] [Related]
15. Managing Seborrheic Keratosis: Evolving Strategies and Optimal Therapeutic Outcomes. Kao S; Kiss A; Efimova T; Friedman AJ J Drugs Dermatol; 2018 Sep; 17(9):933-940. PubMed ID: 30235378 [TBL] [Abstract][Full Text] [Related]
16. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. Kennedy C; Bajdik CD; Willemze R; De Gruijl FR; Bouwes Bavinck JN; J Invest Dermatol; 2003 Jun; 120(6):1087-93. PubMed ID: 12787139 [TBL] [Abstract][Full Text] [Related]
18. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans. Hiraishi Y; Hirobe S; Iioka H; Quan YS; Kamiyama F; Asada H; Okada N; Nakagawa S J Control Release; 2013 Oct; 171(2):93-103. PubMed ID: 23791975 [TBL] [Abstract][Full Text] [Related]
19. Enhancing Outcomes in Seborrheic Keratosis: Using a Novel Treatment Solution. Schlesinger TE; Favre C J Drugs Dermatol; 2019 Jul; 18(7):s178-182. PubMed ID: 31336414 [TBL] [Abstract][Full Text] [Related]
20. Pityrosporum and seborrheic keratosis: an association. Borenstein M; Mirzabeigi M; Vincek V Dermatol Online J; 2005 Aug; 11(2):3. PubMed ID: 16150211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]